Skip to main content
. Author manuscript; available in PMC: 2019 Apr 15.
Published in final edited form as: Clin Cancer Res. 2018 Feb 6;24(8):1795–1804. doi: 10.1158/1078-0432.CCR-17-3351

Figure 3. DFCI Breast Cancer Brain Metastasis translational workflow.

Figure 3

This sample workflow adopted at our institution, Dana Farber Cancer Institute (DFCI) allows for rapid and multi-level analysis of genomic, protein and functional changes (translational research) specific to breast cancer brain metastases. Data from descriptive and functional studies is integrated to identify candidate targets for drug testing in clinical trials (patient care). Images reproduced from Ni et al, Nat Med 2016 and NCI Visuals Online of ‘Treatment Resistant Breast Cancer Cells’ https://visualsonline.cancer.gov/details.cfm?imageid=10574